this makes little sense and doesn't really help make an investment case
firstly you're comparing a $7b baby (MIN) to a $75b behemoth.
secondly FMGs current share price has rallied so aggressively that any drop in iron will cause a massive jitter to the share price.
thirdly MIN is in the middle of a significant growth phase and has many share price catalyst
MIN is well diversified with exposure to lithium which once it reaches its full potential, almost here, it will probably surpass iron ore as a revenue earnerv for the company. In other words, MIN is locked and loaded for the lithium boom with a hand/share in almost all good things lithium. The largest operating mine, another waiting to restart, PLS AND a hydroxide plant about to hit the ground.
when it does reac this potential and gets closer to FMGs iron ore production number in 3-4 years its share price will be $200+ not 36. Yes I said it $200+ and that's conservative. Thats because at 200+ it's market cap will be about$60b. Still lower than FMG and very defendable.
LET THE FACTS SPEAK FOR THEMSELVES.
DYOR AMIGO
Salams
ABZ D
- Forums
- ASX - By Stock
- MIN
- Ann: 2021 Financial Year - Half Year Results Presentation
Ann: 2021 Financial Year - Half Year Results Presentation, page-27
Featured News
Add MIN (ASX) to my watchlist
(20min delay)
|
|||||
Last
$34.95 |
Change
-2.710(7.20%) |
Mkt cap ! $6.868B |
Open | High | Low | Value | Volume |
$36.45 | $36.59 | $34.65 | $92.68M | 2.617M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 516 | $34.95 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$35.05 | 50 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 516 | 34.950 |
13 | 8190 | 34.900 |
2 | 172 | 34.890 |
1 | 1000 | 34.880 |
2 | 248 | 34.850 |
Price($) | Vol. | No. |
---|---|---|
35.080 | 250 | 1 |
35.100 | 21 | 1 |
35.160 | 5111 | 2 |
35.200 | 1722 | 1 |
35.240 | 4767 | 1 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
MIN (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online